Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 30, 2006Current Pharmaceutical Design

Iron Chelation as Therapy for HIV and Mycobacterium tuberculosis Co-Infection Under Conditions of Iron Overload

View Full Paper
Ask AI
Bookmark
Share

Authors

DMDebra MeyerSol Plaatje University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Debra Meyer (2006) studied this question.

synapsesocial.com/papers/6aa5ae235175d8ad94396e4fhttps://doi.org/10.2174/138161206777442164
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Iron Chelator L1 Potentiates Oxidative DNA Damage in Iron-Loaded Liver Cells1998 · 65 citations
  2. 2Efficacy and safety of Efavirenz in HIV patients on Rifampin for tuberculosis2004 · 54 citations